Next-Generation Transcatheter Aortic Valve Replacements Will Drive Rapid Market Growth

By MedTech Intelligence Staff

The market value for transcatheter heart valves will exceed $3 billion by 2020, and adoption of next-generation valves will drive significant market growth, provided that positive clinical data continues, according to research and consulting firm GlobalData.

The market value for transcatheter heart valves will exceed $3 billion by 2020, and adoption of next-generation valves will drive significant market growth, provided that positive clinical data continues, according to research and consulting firm GlobalData.

Continue reading →

Certified Quality PLM Solutions

Trust is one of the first things people mention when you ask what the key to a healthy, happy relationship is. While you might only think of it in terms of your significant other, it applies to other relationships too: family, friends, colleagues – and yes, even your PLM software provider. How do you know you can trust a company though? One way is through ISO certification.

Trust is one of the first things people mention when you ask what the key to a healthy, happy relationship is. While you might only think of it in terms of your significant other, it applies to other relationships too: family, friends, colleagues – and yes, even your PLM software provider. How do you know you can trust a company though? One way is through ISO certification.

Continue reading →

Boston Scientific wins CE Mark and FDA Approval for Thinner, Leadless ICD

By MedTech Intelligence Staff

Using subcutaneous leads, rather than leads threaded through blood vessels to the heart, the EMBLEM Subcutaneous Implantable Defibrillator model is 19 percent slimmer and projected to last 40 percent longer than the original S-ICD, according to the company.

Using subcutaneous leads, rather than leads threaded through blood vessels to the heart, the EMBLEM Subcutaneous Implantable Defibrillator model is 19 percent slimmer and projected to last 40 percent longer than the original S-ICD, according to the company.

Continue reading →

FDA Issues Final Guidance on Reprocessing of Reusable Medical Devices

By MedTech Intelligence Staff

The new recommendations are outlined in a final industry guidance aimed at helping device manufacturers develop safer reusable devices, especially those devices that pose a greater risk of infection.

The new recommendations are outlined in a final industry guidance aimed at helping device manufacturers develop safer reusable devices, especially those devices that pose a greater risk of infection.

Continue reading →

Are You Ready for 3-D Printing?

This technology is poised to deliver cost benefits and advance innovation in manufacturing, and companies will have to focus on replacing old protocols relying on extensive up-front testing and validation of traditional production tools, and understand steps needed to satisfy their quality requirements in the future, describes a new McKinsey report.

This technology is poised to deliver cost benefits and advance innovation in manufacturing, and companies will have to focus on replacing old protocols relying on extensive up-front testing and validation of traditional production tools, and understand steps needed to satisfy their quality requirements in the future, describes a new McKinsey report.

Continue reading →

FDA Unveils Vision for National Post-Market Device Surveillance

By MedTech Intelligence Staff

A recent report describes an ambitious national medical device monitoring system that harnesses novel data sources, modern analytical techniques and the participation of all stakeholders to optimize patient care.

A recent report describes an ambitious national medical device monitoring system that harnesses novel data sources, modern analytical techniques and the participation of all stakeholders to optimize patient care.

Continue reading →

Cardinal to buy J&J’s Cordis Unit?

By MedTech Intelligence Staff

Bloomberg reports that the world’s largest healthcare company Johnson & Johnson is in talks with Cardinal Health Inc. to sell its Cordis unit. The unit may fetch as much as $2 billion in a sale, according to the story.

Bloomberg reports that the world’s largest healthcare company Johnson & Johnson is in talks with Cardinal Health Inc. to sell its Cordis unit. The unit may fetch as much as $2 billion in a sale, according to the story.

Continue reading →

SGS Launches LinkedIn Life Sciences Community

The page will provide the life sciences community with a place to share ideas and find out about the latest laboratory bio/analytical and clinical research news and trends.

The page will provide the life sciences community with a place to share ideas and find out about the latest laboratory bio/analytical and clinical research news and trends.

Continue reading →